| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $22.6M | -9.2% |
| R&D Expense | $5.7M | -5.6% |
| SG&A Expense | $14.7M | -8.8% |
| Operating Income | -$19.6M | -81.4% |
| Interest Expense | $1.1M | +43.0% |
| Pre-tax Income | -$18.7M | -65.7% |
| Income Tax | -$46K | -164.8% |
| Net Income | -$18.7M | -64.3% |
| EPS (Basic) | -$0.33 | -43.5% |
| EPS (Diluted) | -$0.33 | -43.5% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.2M | -51.7% |
| Accounts Receivable | $4.2M | -45.1% |
| Current Assets | $8.8M | -44.7% |
| Total Assets | $41.7M | -32.2% |
| Current Liabilities | $13.7M | -18.4% |
| Long-term Debt | $9.1M | -6.7% |
| Total Liabilities | $22.9M | -11.9% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.2M | +69.0% |
| Capital Expenditures | $54K | +440.0% |
| Investing Cash Flow | -$1.6M | +16.2% |
| Financing Cash Flow | $428K | -92.6% |
| Free Cash Flow | -$2.3M | +68.3% |
| Stockholders' Equity |
| $18.8M |
| -47.0% |